CN109675065A - Nanometer magnetic bead and preparation method thereof for T1 and T2 magnetic resonance bimodal radiography - Google Patents

Nanometer magnetic bead and preparation method thereof for T1 and T2 magnetic resonance bimodal radiography Download PDF

Info

Publication number
CN109675065A
CN109675065A CN201811560470.8A CN201811560470A CN109675065A CN 109675065 A CN109675065 A CN 109675065A CN 201811560470 A CN201811560470 A CN 201811560470A CN 109675065 A CN109675065 A CN 109675065A
Authority
CN
China
Prior art keywords
magnetic bead
magnetic resonance
nanometer
preparation
polyacrylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811560470.8A
Other languages
Chinese (zh)
Inventor
李天亮
崔大祥
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Jiaotong University
Original Assignee
Shanghai Jiaotong University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Jiaotong University filed Critical Shanghai Jiaotong University
Priority to CN201811560470.8A priority Critical patent/CN109675065A/en
Publication of CN109675065A publication Critical patent/CN109675065A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A61K49/1851Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
    • A61K49/1854Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly(meth)acrylate, polyacrylamide, polyvinylpyrrolidone, polyvinylalcohol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/12Macromolecular compounds
    • A61K49/126Linear polymers, e.g. dextran, inulin, PEG

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The present invention relates to a kind of nanometer magnetic beads and preparation method thereof for T1 and T2 magnetic resonance bimodal radiography, the nanometer magnetic bead includes nano ferriferrous oxide magnetic bead and the polyacrylic acid shell being wrapped in outside nano ferriferrous oxide magnetic bead, when preparation, trivalent iron salt and divalent ferrous salt are dissolved in concentrated hydrochloric acid, obtain salting liquid, salting liquid is added into polyacrylic acid aqueous solution, after mixing, in N2It is heated to reflux under environment, concentrated ammonia liquor is then added, to which after reaction, cooling, filtering purifies to get product.Compared with prior art, the present invention provides a kind of preparation method of extra small nanometer magnetic bead for the imaging of T1 and T2 magnetic resonance bimodal, the method process is simple, reaction condition is mild, at low cost, pollution-free, and it is metabolizable in the contrast agent body, it can be used for clinical magnetic resonance contrast agent.

Description

Nanometer magnetic bead and preparation method thereof for T1 and T2 magnetic resonance bimodal radiography
Technical field
The present invention relates to Nano Medicine Materials technical fields, and in particular to one kind is used for T1 and T2 magnetic resonance bimodal radiography Nanometer magnetic bead and preparation method thereof.
Background technique
Nano iron oxide magnetic bead is a kind of nontoxic contrast agent, in clinical science research as iron-based contrast agent It is mainly used for T2 magnetic resonance radiography, does not have T1 magnetic resonance radiography effect substantially.And the clinically main magnetic resonance used at present Contrast agent is gadolinium agent, is used for T1 magnetic resonance radiography, and contrasting effects are good, and metabolism is fast, can not still be substituted up to now.However, U.S. FDA announces explanation, and gadolinium ion is a kind of heavy metal ion, has certain toxicity to kidney and cranial nerve.Therefore one kind is prepared Alternatively, nontoxic, metabolizable clinic has great importance with T1 and T2 bimodal magnetic resonance contrast agent.
Summary of the invention
T1 can be realized simultaneously it is an object of the present invention to overcome the above-mentioned drawbacks of the prior art and provide a kind of With T2 bimodal magnetic resonance radiography and the nanometer magnetic bead for T1 and T2 magnetic resonance bimodal radiography of nonhazardous and its preparation side Method.
The purpose of the present invention can be achieved through the following technical solutions: one kind being used for T1 and T2 magnetic resonance bimodal radiography Nanometer magnetic bead, which includes nano ferriferrous oxide magnetic bead and is wrapped in outside nano ferriferrous oxide magnetic bead The mass ratio of polyacrylic acid shell, the nano ferriferrous oxide magnetic bead and polyacrylic acid shell is 1:0.01~0.1.
Negative (T2) contrasting effects that ferriferrous oxide nano magnetic bead prepared by the present invention is assigned in addition to ferroso-ferric oxide itself Outside, super-small causes the specific surface area of ferroso-ferric oxide to greatly increase than large scale ferriferrous oxide particles, causes it vertical It is greatly increased to relaxation rate, therefore the ferroferric oxide nano granules of super-small have positive (T1) contrasting effects simultaneously.
It is that one kind is more that the structural adoption polyacrylic acid of nanometer magnetic bead prepared by the present invention, which is due to polyacrylic acid molecule, Carboxyl polymer, a large amount of carboxyl can form very strong metal with ferric ion, ferrous ion in molecular structure Chelation, and then the ferroferric oxide nano granules size for having delayed concentrated ammonia liquor to the precipitation of iron ion, therefore having been formed It is very small, and polyacrylic acid is coated on ferroso-ferric oxide surface and forms shell structure can promote its dispersion in water very well Degree.
Preferably, the diameter of the nano ferriferrous oxide magnetic bead is 2~10nm, the thickness of the polyacrylic acid shell For 0.1~1nm.
A kind of preparation method for the nanometer magnetic bead of T1 and T2 magnetic resonance bimodal radiography, including following step as described above It is rapid:
Trivalent iron salt and divalent ferrous salt are dissolved in concentrated hydrochloric acid, salting liquid is obtained, salting liquid is added to polyacrylic acid In aqueous solution, after mixing, in N2It is heated to reflux under environment, concentrated ammonia liquor is then added, to after reaction, cool down, filter, Purifying is to get the nanometer magnetic bead for T1 and T2 magnetic resonance bimodal radiography.
Trivalent iron salt and divalent ferrous salt are dissolved in concentrated hydrochloric acid, salting liquid is obtained, salting liquid is added to polyacrylic acid In aqueous solution, after mixing, in N2It is heated to reflux under environment, concentrated ammonia liquor is then added, to after reaction, cool down, filter, Purifying is to get the nanometer magnetic bead for T1 and T2 magnetic resonance bimodal radiography.It is molten after concentrated ammonia liquor is added in preparation process Hydroxyl concentration increases in liquid, and ferric ion and ferrous ion form hydroxide precipitating, and subsequent sediment is hydrolyzed into four Fe 3 O, due to the presence of polyacrylic acid, the particle of the ferroso-ferric oxide of formation is limited in extra small size range.
Preferably, the trivalent iron salt is ferric chloride hexahydrate, and divalent ferrous salt is green vitriol, the Fe3+ And Fe2+Molar ratio be (0.5~5): 1.
Preferably, the molar concentration of the concentrated hydrochloric acid is 0.03M~0.34M, Fe in the salting liquid3+Molar concentration be 1 μM~5M.Molysite is dispersed using concentrated hydrochloric acid, is because concentrated hydrochloric acid can be improved the solubility of green vitriol in water.
Preferably, the molecular weight of the acrylic acid is 1000~1000000, the polyacrylic acid aqueous solution kind polyacrylic acid Molar concentration be salting liquid in Fe3+0.02~2 times of molar concentration.The additional proportion of polyacrylic acid is excessively high or too low meeting Lead to that ferroso-ferric oxide can not generate or nano-scale is excessive.
Preferably, the molar concentration of the concentrated ammonia liquor is Fe in salting liquid3+1000~30000 times of molar concentration.It is dense The additional proportion of ammonium hydroxide is too low or too high to will lead to that ferroso-ferric oxide can not generate or nano-scale is excessive.
Preferably, the temperature of the reflux is 25~100 DEG C, and return time is 0.5~2h.Temperature change will affect four oxygen Change the crystallinity of iron, and then influences its contrasting effects.
Preferably, the temperature of the reaction is 25~100 DEG C, and the reaction time is 0.5~2h.Reaction time will affect four oxygen Change the crystallinity of iron, and then influences its contrasting effects
Preferably, the purifying is by the way of pure water dialysis and filter centrifugation.
Compared with prior art, the beneficial effects of the present invention are embodied in following several respects:
(1) the method process is simple, and reaction condition is mild, at low cost, pollution-free.It is metabolizable in vivo, it can be used for clinical magnetic Resonate contrast agent;
(2) the ferriferrous oxide nano magnetic bead of the method preparation has fabulous dispersibility in water, can be achieved at the same time T1 and T2 bimodal contrasting effects.
Detailed description of the invention
Fig. 1 is that ferriferrous oxide nano magnetic bead and Magnevist Solution injection are right in vitro (material itself) in embodiment 1 Front and back (material in nude mouse is injected into than ferriferrous oxide nano magnetic bead in T1 and T2 bimodal contrasting effects and embodiment 1 By in tail vein injection to nude mouse) comparison T1 and T2 bimodal contrasting effects;
Fig. 2 is the structural schematic diagram of ferriferrous oxide nano magnetic bead preparation facilities in embodiment 1, wherein 1 is heating stirring Device, 2 be reaction flask, and 3 blast plug for gas, and 4 be return pipe, and 5 be feed injector;
Fig. 3 is the transmission electron microscope shape appearance figure of the ferriferrous oxide nano magnetic bead prepared in embodiment 1.
Specific embodiment
It elaborates below to the embodiment of the present invention, the present embodiment carries out under the premise of the technical scheme of the present invention Implement, the detailed implementation method and specific operation process are given, but protection scope of the present invention is not limited to following implementation Example.
Embodiment 1
A kind of preparation method of the nanometer magnetic bead for T1 and T2 magnetic resonance bimodal radiography, comprising the following steps: reaction Bottle 2 is placed on heating stirrer 1, and 40mL deionized water and 0.8g polypropylene is added by feed injector 5 in reaction flask 2 Acid, opens heating stirrer 1, and stirring, which to dissolving, in reaction flask 2 by gas blasts plug 3 and blasts nitrogen into reaction flask 2, arranges Except extra oxygen, the trivalent iron salt and divalent ferrous salt being quickly dissolved under stirring in concentrated hydrochloric acid are fast by feed injector 5 Speed injection, the device of use are as shown in Figure 2, wherein the molar concentration of trivalent iron salt is 1M, and the concentration of divalent ferrous salt is 0.5M, following reaction bottle 2 are heated to 100 DEG C, and after temperature is stablized, 8mL concentrated ammonia liquor is injected into rapidly anti-by feed injector 5 It answers in bottle 2, cooling after reacting 2h, the mode of the dialysis of little magnetic bead pure water and filter centrifugation is purified, and contrast agent is obtained, to it Transmission electron microscopy is carried out, shape appearance figure is as shown in figure 3, therefrom it can be found that the dispersibility of contrast agent is better.
To disperse after the contrast agent ferriferrous oxide nano magnetic beads for purifying being prepared in aqueous solution, with it is identical from The gadolinium of sub- concentration sprays sour Pu'an dispersion liquid and carries out external comparison T1 and T2 bimodal contrasting effects (attached drawing 1 (a) and attached drawing 1 (b)), test transfers to Shanghai Niu Mai company to measure, and test parameter is, and repetition time/echo time (TR/TE)= 1150/11.5ms;Acquisition=256 × 192 matrix;Number of excitations=8;field of View (FOV)=80mm × 80mm;FOV phase of 40%, thickness=5.0mm;0.5T,and 32℃.Test knot Fruit shows, under same ion concentration, ferriferrous oxide nano magnetic bead is brighter under T1 weighted imaging mode, and (pcolor color is more It is red), darker under T1 weighted imaging mode (pcolor color is more blue), this is the result shows that ferriferrous oxide nano magnetic bead compares gadolinium The Portugal Pen Suan amine has better T1 and T2 magnetic resonance imaging effect.
It will be dispersed in phosphate buffer solution after the ferriferrous oxide nano magnetic beads for purifying of preparation, pass through tail vein injection Into nude mouse, T1 the and T2 magnetic resonance imaging effect (attached drawing 1 (c) and attached drawing 1 (d)) of nude mice is tested.Test is by Shanghai traffic The attached Sixth Man people hospital radiological department of university (MAGENTOM, Verio, Siemens Healthcare, Erlangen, Germany it) measures, parameter is set as TR/TE=1200/12ms;Matrix=256 × 256 acquisition;field of View=100 × 100mm;Number of slices=12;Slice thickness=2mm;Flip angle=150 °. Test result is shown, under T1 sequence, 2h after the injection of ferriferrous oxide nano magnetic bead, and before injection, the tissue contours of nude mice It is more clear, the magnetic resonance signal in kidney region is brighter, this shows that super-small nano ferriferrous oxide granule has enhancing T1 The characteristics of effect and kidney approach metabolism of magnetic resonance radiography;Similarly, under T2 sequence, after the injection of ferriferrous oxide nano magnetic bead 2h, before injection, the tissue contours of nude mice are more clear, and the magnetic resonance signal in kidney region is more black, this shows super-small Nano ferriferrous oxide granule has the effect of the characteristics of enhancing T2 magnetic resonance radiography and the metabolism of kidney approach.
Embodiment 2
Using preparation method similar to Example 1, the difference is that:
(1)Fe3+And Fe2+Molar ratio be 0.5:1;
(2) molar concentration of concentrated hydrochloric acid is 0.03M, Fe in the salting liquid3+Molar concentration be 5M;
(3) molar concentration of polyacrylic acid aqueous solution kind polyacrylic acid is Fe in salting liquid3+0.02 times of molar concentration;
(4) molar concentration of concentrated ammonia liquor is Fe in salting liquid3+1000 times of molar concentration;
(5) temperature to flow back is 25 DEG C, return time 2h;
(6) temperature reacted is 25 DEG C, reaction time 2h;
Through detecting, the contrast agent that the present embodiment is prepared can be achieved at the same time T1 and T2 bimodal contrasting effects.
Embodiment 3
Using preparation method similar to Example 1, the difference is that:
(1)Fe3+And Fe2+Molar ratio be 5:1;
(2) molar concentration of concentrated hydrochloric acid is 0.34M, Fe in the salting liquid3+Molar concentration be 1 μM;
(3) molar concentration of polyacrylic acid aqueous solution kind polyacrylic acid is Fe in salting liquid3+2 times of molar concentration;
(4) molar concentration of concentrated ammonia liquor is Fe in salting liquid3+30000 times of molar concentration;
(5) temperature to flow back is 100 DEG C, return time 0.5h;
(6) temperature reacted is 100 DEG C, reaction time 0.5h;
Through detecting, the contrast agent that the present embodiment is prepared can be achieved at the same time T1 and T2 bimodal contrasting effects.

Claims (10)

1. a kind of nanometer magnetic bead for T1 and T2 magnetic resonance bimodal radiography, which is characterized in that the nanometer magnetic bead includes nanometer Ferroso-ferric oxide magnetic bead and the polyacrylic acid shell being wrapped in outside nano ferriferrous oxide magnetic bead, the oxidation of nanometer four three The mass ratio of ferromagnetic pearl and polyacrylic acid shell is 1:(0.01~0.1).
2. a kind of nanometer magnetic bead for T1 and T2 magnetic resonance bimodal radiography according to claim 1, which is characterized in that The diameter of the nano ferriferrous oxide magnetic bead be 2~10nm, the polyacrylic acid shell with a thickness of 0.1~1nm.
3. a kind of preparation method for the nanometer magnetic bead of T1 and T2 magnetic resonance bimodal radiography as claimed in claim 1 or 2, It is characterized in that, comprising the following steps:
Trivalent iron salt and divalent ferrous salt are dissolved in concentrated hydrochloric acid, salting liquid is obtained, salting liquid is added water-soluble to polyacrylic acid In liquid, after mixing, in N2It is heated to reflux under environment, concentrated ammonia liquor is then added, to which after reaction, cooling filters, is pure Change to get the nanometer magnetic bead for T1 and T2 magnetic resonance bimodal radiography.
4. a kind of preparation method of nanometer magnetic bead for T1 and T2 magnetic resonance bimodal radiography according to claim 3, It is characterized in that, the trivalent iron salt is ferric chloride hexahydrate, divalent ferrous salt is green vitriol, the Fe3+And Fe2 +Molar ratio be (0.5~5): 1.
5. a kind of preparation method of nanometer magnetic bead for T1 and T2 magnetic resonance bimodal radiography according to claim 4, It is characterized in that, the molar concentration of the concentrated hydrochloric acid is 0.03M~0.34M, Fe in the salting liquid3+Molar concentration be 1 μM ~5M.
6. a kind of preparation method of nanometer magnetic bead for T1 and T2 magnetic resonance bimodal radiography according to claim 5, It is characterized in that, the molecular weight of the acrylic acid is 1000~1000000, the polyacrylic acid aqueous solution kind polyacrylic acid rubs Your concentration is Fe in salting liquid3+0.02~2 times of molar concentration.
7. a kind of preparation method of nanometer magnetic bead for T1 and T2 magnetic resonance bimodal radiography according to claim 5, It is characterized in that, the molar concentration of the concentrated ammonia liquor is Fe in salting liquid3+1000~30000 times of molar concentration.
8. a kind of preparation method of nanometer magnetic bead for T1 and T2 magnetic resonance bimodal radiography according to claim 3, It is characterized in that, the temperature of the reflux is 25~100 DEG C, return time is 0.5~2h.
9. a kind of preparation method of nanometer magnetic bead for T1 and T2 magnetic resonance bimodal radiography according to claim 3, It is characterized in that, the temperature of the reaction is 25~100 DEG C, the reaction time is 0.5~2h.
10. a kind of preparation method of nanometer magnetic bead for T1 and T2 magnetic resonance bimodal radiography according to claim 3, It is characterized in that, the purifying is by the way of pure water dialysis and filter centrifugation.
CN201811560470.8A 2018-12-20 2018-12-20 Nanometer magnetic bead and preparation method thereof for T1 and T2 magnetic resonance bimodal radiography Pending CN109675065A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811560470.8A CN109675065A (en) 2018-12-20 2018-12-20 Nanometer magnetic bead and preparation method thereof for T1 and T2 magnetic resonance bimodal radiography

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811560470.8A CN109675065A (en) 2018-12-20 2018-12-20 Nanometer magnetic bead and preparation method thereof for T1 and T2 magnetic resonance bimodal radiography

Publications (1)

Publication Number Publication Date
CN109675065A true CN109675065A (en) 2019-04-26

Family

ID=66186953

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811560470.8A Pending CN109675065A (en) 2018-12-20 2018-12-20 Nanometer magnetic bead and preparation method thereof for T1 and T2 magnetic resonance bimodal radiography

Country Status (1)

Country Link
CN (1) CN109675065A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112133553A (en) * 2020-10-30 2020-12-25 福州大学 Continuous preparation method of water-based magnetofluid
WO2021190573A1 (en) * 2020-03-23 2021-09-30 中国科学院宁波材料技术与工程研究所 Magnetic nanocomposite material and preparation method therefor and use thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101649101A (en) * 2008-08-15 2010-02-17 中国人民解放军军事医学科学院毒物药物研究所 Magnetic nanoparticles with novel nuclear shell structure and pH responsibility as well as application thereof
CN101830516A (en) * 2010-05-18 2010-09-15 浙江大学 Method for preparing nano ferroferric oxide particles
CN104016416A (en) * 2014-06-17 2014-09-03 南京大学 Method for preparing polyacrylate nano alpha-Fe2O3
CN104560949A (en) * 2014-11-04 2015-04-29 华文蔚 Preparation method of magnetic nanoparticle for fast extracting DNA
CN104758956A (en) * 2015-04-03 2015-07-08 国家纳米科学中心 Tumor-targeted T1-T2 double nuclear magnetic resonance imaging contrast agent and preparation method and application thereof
CN108392642A (en) * 2018-02-23 2018-08-14 莎穆(上海)生物科技有限公司 A kind of nano-particle magnetic resonance imaging contrast and its preparation method and application containing gadolinium oxide

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101649101A (en) * 2008-08-15 2010-02-17 中国人民解放军军事医学科学院毒物药物研究所 Magnetic nanoparticles with novel nuclear shell structure and pH responsibility as well as application thereof
CN101830516A (en) * 2010-05-18 2010-09-15 浙江大学 Method for preparing nano ferroferric oxide particles
CN104016416A (en) * 2014-06-17 2014-09-03 南京大学 Method for preparing polyacrylate nano alpha-Fe2O3
CN104560949A (en) * 2014-11-04 2015-04-29 华文蔚 Preparation method of magnetic nanoparticle for fast extracting DNA
CN104758956A (en) * 2015-04-03 2015-07-08 国家纳米科学中心 Tumor-targeted T1-T2 double nuclear magnetic resonance imaging contrast agent and preparation method and application thereof
CN108392642A (en) * 2018-02-23 2018-08-14 莎穆(上海)生物科技有限公司 A kind of nano-particle magnetic resonance imaging contrast and its preparation method and application containing gadolinium oxide

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
XIWEN YANG等: "One-step hydrothermal synthesis of highly water-soluble secondary structural Fe3O4 nanoparticles", 《JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021190573A1 (en) * 2020-03-23 2021-09-30 中国科学院宁波材料技术与工程研究所 Magnetic nanocomposite material and preparation method therefor and use thereof
CN112133553A (en) * 2020-10-30 2020-12-25 福州大学 Continuous preparation method of water-based magnetofluid
CN112133553B (en) * 2020-10-30 2021-12-21 福州大学 Continuous preparation method of water-based magnetofluid

Similar Documents

Publication Publication Date Title
Li et al. One-pot preparation of hydrophilic manganese oxide nanoparticles as T1 nano-contrast agent for molecular magnetic resonance imaging of renal carcinoma in vitro and in vivo
Digigow et al. Preparation and characterization of functional silica hybrid magnetic nanoparticles
CN104745192B (en) A kind of magnetic fluorescent dual-function nanoparticle probe and preparation method thereof
US8409544B2 (en) Preparation method of ferroferric oxide magnetic nanospheres
JP5701408B2 (en) Method for preparing iron oxide nanoparticles coated with hydrophilic substance, and magnetic resonance imaging contrast agent containing iron oxide nanoparticles
Yang et al. One-step hydrothermal synthesis of highly water-soluble secondary structural Fe3O4 nanoparticles
JP5765520B2 (en) Method for producing aqueous dispersion containing magnetic particles
JP5700590B2 (en) Spherical ferrite nanoparticles and manufacturing method thereof
EP2922577B1 (en) Superparamagnetic iron oxide nanoparticles with ultra-thin polymer layers
CN106913885B (en) Magnetic nano particle and preparation method and application thereof
CN110496970A (en) A kind of composite nano materials, preparation method and its application
CN109675065A (en) Nanometer magnetic bead and preparation method thereof for T1 and T2 magnetic resonance bimodal radiography
CN102344170B (en) Method for preparing water-based Fe3O4 magnetic fluid by using polyamide-amine dendrimer as template
CN103623436A (en) Magnetic rare earth nanoparticle with biocompatibility, preparation method thereof, and applications of magnetic rare earth nanoparticle in magnetic resonance imaging
CN106315684A (en) Preparation method of size-controllable spherical MnZn ferrite magnetic nanoparticles
CN111477420A (en) Magnetic nano particle, preparation method and application thereof
CN103303981B (en) Ferroferric oxide nanoparticle as well as preparation method and application thereof
Gaharwar et al. Magnetic nanoparticles encapsulated within a thermoresponsive polymer
CN107802845B (en) Method for phase conversion of hydrophobic nanoparticles by using silk fibroin molecules
Liu et al. Synthesis and characterization of iron oxide/polymer composite nanoparticles with pendent functional groups
CN107224588B (en) Preparation method of drug carrier with magnetic-pH value dual response
JP2014156411A (en) Composite magnetic particulate powder, and dispersion
CN103110965A (en) Ferroferric oxide nanometer material as well as preparation method and application thereof
Shao et al. Characterization of Fe 3 O 4/SiO 2 composite core-shell nanoparticles synthesized in isopropanol medium
CN110550666A (en) Monodisperse and superparamagnetic ferroferric oxide nanoflower and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information
CB02 Change of applicant information

Address after: 200030 Dongchuan Road, Minhang District, Minhang District, Shanghai

Applicant after: SHANGHAI JIAO TONG University

Address before: 200030 Huashan Road, Shanghai, No. 1954, No.

Applicant before: SHANGHAI JIAO TONG University

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20190426